Wednesday, July 18, 2018
 
 
Company News: Page (1) of 1 - 07/12/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
2018 Global Strategic Business Report: Direct-to-Consumer (DTC) Genetic Testing - High Potential Benefits, But Concerns Persist
 
(July 12, 2018)

DUBLIN, July 12, 2018 /PRNewswire/ --

The "Direct-to-Consumer (DTC) Genetic Testing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets.

This report analyzes the worldwide markets for Cardiology IT Workflow Solutions in US$ Thousand.

The report profiles 84 companies including many key and niche players such as:



  • 23andMe, Inc. (USA)
  • Ancestry.com, LLC (USA)
  • Any Lab Test Now (USA)
  • Color Genomics, Inc. (USA)
  • Counsyl, Inc. (USA)
  • Direct Laboratory Services, LLC (USA)
  • Gene by Gene, Ltd. (USA)
  • Laboratory Corporation of America Holdings (USA)
  • Mapmygenome India Limited (India)
  • Positive Bioscience, Inc. (India)
  • Quest Diagnostics, Inc. (USA)
  • Request A Test, Ltd. (USA)
  • Sonora Quest Laboratories LLC (USA)
  • Xcode Life Sciences (India)

Key Topics Covered

1. INDUSTRY OVERVIEW
Genetic Testing: A Synopsis
Direct-to-Consumer (DTC) Genetic Testing: An Overview
Market Overview
Major Factors Impacting DTC Genetic Testing Market
Consumers Self-Managing Treatments: The New Trend
Authorities Grappling With Setting Appropriate Regulations for DTC Genetic Testing
Changing Landscape of DTC Genetic Testing
Regulations to Determine Market Viability
Potential Benefits Outweigh Concerns
DTC Genetic Testing: High Potential Benefits, But Concerns Persist
Quality Assurance
Confidentiality of Genetic Information
Price and Related Services
Greater Chances of Misinterpretation
Regulatory Headwinds and Data Paucity Impacting DTC Genetic Testing Market
Despite Progress in DTC Genetic Testing Regulations, Concerns Still Linger
Transparency of Data: Bugbear of DTC Genetic Testing Companies
The Contextual Privacy Conundrum
Increasing Adoption Raises the Threat of Data Breach
DTC Genetic Testing Companies
An Unregulated Lot
Association for Molecular Pathology v. Myriad Genetics, Inc. Ruling Removes Potential Barriers for DTC Genetic Testing Companies
Competitive Scenario
Recent Transactions in DTC Genetics Testing Market

2. OVERVIEW OF DTC GENETIC TESTING BY MODALITY
Non-Invasive Prenatal Genetic Testing
A Resounding Success
DTC Genetic Testing in Ophthalmology
Seeking an Easy Way Out
DTC Genetic Testing in Cystic Fibrosis

3. DIRECT-TO-CONSUMER GENETIC TESTING: AN OVERVIEW
DTC Genetic Testing
An Introduction
Process of DTC Genetic Testing
Preface to Genetic Testing
Genetic Testing and Applications
Advantages of DTC Genetic Testing
Risks Involved in DTC Genetic Testing
Interpretation of Results
Positive Tested Result
Negative Tested Result
Select DTC Genetic Testing Companies and Tests Offered

4. PRODUCTS INNOVATIONS/INTRODUCTIONS
MyHeritage Introduces MyHeritage DNA Services to Help Uncover Familial Ethnicity and History
23andMe Reintroduces Genetic Testing Kit for Fewer Diseases in US Market
LabCorp Launches VistaSeq Hereditary Cancer Panel Focusing on Commonly Diagnosed Cancers
Quest Diagnostics and Inserm Launch BRCA Share, a Datashare Initiative with Open Access to BRCA1 and BRCA2 Genetic Data
23andMe Rolls Out Personal Genome Service in the UK

5. RECENT INDUSTRY ACTIVITY
Color Genomics Raises US$45 million in Series B Funding Led by General Catalyst
Human Longevity Closes US$220 million Series B Funding
Silver Lakes and GIC Acquire Minority Stake in Ancestry.com
23andMe Bags FDA Approval for Personal Genome Service, a DTC Genetic Test for Bloom Syndrome
23andMe Completes US$ 115 million Series E Financing
Angel Investors Pump in US$1.1 million into Mapmygenome in Pre-series A Funding

6. FOCUS ON SELECT PLAYERS
23andMe, Inc. (USA)
Ancestry.com, LLC (USA)
Any Lab Test Now (USA)
Color Genomics, Inc. (USA)
Counsyl, Inc. (USA)
Direct Laboratory Services, LLC (USA)
Gene by Gene, Ltd. (USA)
Laboratory Corporation of America Holdings (USA)
Mapmygenome India Limited (India)
Positive Bioscience, Inc. (India)
Quest Diagnostics, Inc. (USA)
Request A Test, Ltd. (USA)
Sonora Quest Laboratories LLC (USA)
Xcode Life Sciences (India)

7. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 41 (including Divisions/Subsidiaries 43)

  • The United States (28)
  • Canada (3)
  • Europe (8)
    • The United Kingdom (4)
    • Rest of Europe (4)
  • Asia-Pacific (Excluding Japan) (3)
  • Middle East (1)

For more information about this report visit https://www.researchandmarkets.com/research/f6nn4d/directtoconsumer?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/2018-global-strategic-business-report-direct-to-consumer-dtc-genetic-testing---high-potential-benefits-but-concerns-persist-300680286.html

SOURCE Research and Markets

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:India, Inc.,Aging,Surgery,Science,Medical,Agricultural Science,Biology,Genetics,Cancer,Business,india,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Robotics Prosthetics Market Exclusive Analysis by MRFR | Industry Growing with 9.5% CAGR up to 2027 | The Demand for Robotic Prosthetic is Found to be Increasing across the Globe
  • Implantable Medical Devices Market Predicted to be Worth US$ 49.8 Bn by 2024, Says TMR
  • Global Cosmetic Chemicals Industry
  • HMP's 8th Annual Amputation Prevention Symposium Expected to Draw 800 Clinicians to Chicago to Join the CLI Revolution

    Cancer
  • Camurus Announces PDUFA Date for CAM2038 for the Treatment of Opioid use Disorder
  • Omega-3 Market to Reach US$ 16.37 Bn by 2023, Globally - QYResearch.com
  • Association of Community Cancer Centers and Advisory Board Launch 9th Annual Trends in Cancer Care Survey
  • Small Animal Imaging Market is Estimated to Grow at a Faster Pace With the Significant CAGR During the Forecast Period: Radiant Insights, Inc.
  • Presage Biosciences Closes Series D Financing with Takeda and Celgene, and Announces Appointment of Richard Klinghoffer, PhD as Chief Executive Officer
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines